In summary, our findings demonstrate the in vivo molecular, cellular, behavioral and survival effects of anti-tau sdAbs in minimizing or preventing the development of various tau-induced phenotypes in Drosophila tauopathy models. This evidence concerns the gene MAPT and tauopathy.